Premium
P3‐265: KMS88009 and KMS88016 as small molecule inhibitors for in vivo Aβ fibril formation
Author(s) -
Kim YoungSoo,
Byun Ji Hun,
Ryu Jiyeon,
Hwang Hana,
Lee Ji Hoon,
Cho Jeiwon,
Ahn YoungGil,
Kim Young Hoon,
Kim Maeng Sup,
Lee Gwan Sun,
MookJung Inhee,
Yoo Kyung Ho,
Kim Dong Jin
Publication year - 2009
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2009.04.936
Subject(s) - in vivo , fibril , thioflavin , chemistry , in vitro , mtt assay , pharmacology , donepezil , neurotoxicity , ex vivo , acetylcholinesterase , genetically modified mouse , cholinergic , curcumin , ic50 , cytotoxicity , biochemistry , biophysics , toxicity , transgene , alzheimer's disease , pathology , neuroscience , medicine , biology , dementia , enzyme , disease , microbiology and biotechnology , organic chemistry , gene
YoungSoo Kim, Ji Hun Byun, Jiyeon Ryu, Hana Hwang, Ji Hoon Lee, Jeiwon Cho, HyeYun Kim, Young-Gil Ahn, Young Hoon Kim, Maeng Sup Kim, Gwan Sun Lee, Inhee Mook-Jung, Kyung Ho Yoo, Dong Jin Kim, Korea Institute of Science and Technology, Seoul, Republic of Korea; Hanmi Research Center, Hanmi Pharm. Co., Ltd., Seoul, Republic of Korea; Seoul National University College of Medicine, Seoul, Republic of Korea. Contact e-mail: yskim@kist.re.kr